Translating your analytical tests to the GMP level to accelerate filing submission for clinical trials

At the event “Towards the Future: Synergizing Efforts for the Next Generation of Cell Therapeutics” in Niel on 13^th of June”, Griet Nuytinck (CEO Anacura) and Nathalie Van Bruaene (Head cell-based division Anacura LS) presented how Anacura is part of the value chain in cell therapy development during their talk:

Translating your analytical tests to the GMP level to accelerate filing submission for clinical trials

• Development of new ATMP’s is challenging, often combined with multiple obstacles and huge time pressure
• To save time & extra resources the cell-based team of Anacura can help to accelerate by translating & validating your analytical tests. This was shown by several practical examples

Interested in our services for your cell therapy development journey? Contact us and we are happy to help you!